204 related articles for article (PubMed ID: 23277397)
21. Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.
Cai Y; Yi J; Zhou C; Shen X
PLoS One; 2012; 7(10):e47769. PubMed ID: 23082213
[TBL] [Abstract][Full Text] [Related]
22. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
Wang PY; Xie SY; Hao Q; Zhang C; Jiang BF
Int J Tuberc Lung Dis; 2012 May; 16(5):589-95. PubMed ID: 22409928
[TBL] [Abstract][Full Text] [Related]
23. Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs.
Chamorro JG; Castagnino JP; Musella RM; Nogueras M; Aranda FM; Frías A; Visca M; Aidar O; Perés S; de Larrañaga GF
J Gastroenterol Hepatol; 2013 Feb; 28(2):323-8. PubMed ID: 23190413
[TBL] [Abstract][Full Text] [Related]
24. NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
Wattanapokayakit S; Mushiroda T; Yanai H; Wichukchinda N; Chuchottawon C; Nedsuwan S; Rojanawiwat A; Denjanta S; Kantima T; Wongyai J; Suwankesawong W; Rungapiromnan W; Kidkeukarun R; Bamrungram W; Chaiwong A; Suvichapanich S; Mahasirimongkol S; Tokunaga K
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1364-1369. PubMed ID: 27725049
[TBL] [Abstract][Full Text] [Related]
25. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
Suvichapanich S; Fukunaga K; Zahroh H; Mushiroda T; Mahasirimongkol S; Toyo-Oka L; Chaikledkaew U; Jittikoon J; Yuliwulandari R; Yanai H; Wattanapokayakit S; Tokunaga K
Pharmacogenet Genomics; 2018 Jul; 28(7):167-176. PubMed ID: 29781872
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis.
Cho HJ; Koh WJ; Ryu YJ; Ki CS; Nam MH; Kim JW; Lee SY
Tuberculosis (Edinb); 2007 Nov; 87(6):551-6. PubMed ID: 17950035
[TBL] [Abstract][Full Text] [Related]
27.
Richardson M; Kirkham J; Dwan K; Sloan DJ; Davies G; Jorgensen AL
Int J Tuberc Lung Dis; 2019 Mar; 23(3):293-305. PubMed ID: 30871660
[TBL] [Abstract][Full Text] [Related]
28. Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.
Ben Fredj N; Gam R; Kerkni E; Chaabane A; Chadly Z; Boughattas N; Aouam K
Pharmacogenomics J; 2017 Jul; 17(4):372-377. PubMed ID: 27089936
[TBL] [Abstract][Full Text] [Related]
29.
Mohamed Noor NF; Salleh MZ; Mohd Zim MA; Bakar ZA; Fakhruzzaman Noorizhab MN; Zakaria NI; Lailanor MI; Teh LK
Pharmacogenomics; 2022 Jun; 23(9):531-541. PubMed ID: 35615896
[No Abstract] [Full Text] [Related]
30. Determining the relation between N-acetyltransferase-2 acetylator phenotype and antituberculosis drug induced hepatitis by molecular biologic tests.
Bozok Cetintaş V; Erer OF; Kosova B; Ozdemir I; Topçuoğlu N; Aktoğu S; Eroğlu Z
Tuberk Toraks; 2008; 56(1):81-6. PubMed ID: 18330759
[TBL] [Abstract][Full Text] [Related]
31. Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.
Wang N; Guo S; Liu H; Ding Y; Yao R; Liu Z; Zhu H; Chen X; Yang X; Chen X; Lu Y
Xenobiotica; 2022 May; 52(5):520-526. PubMed ID: 35723590
[TBL] [Abstract][Full Text] [Related]
32. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
Sun F; Chen Y; Xiang Y; Zhan S
Int J Tuberc Lung Dis; 2008 Sep; 12(9):994-1002. PubMed ID: 18713495
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation.
Roy B; Chowdhury A; Kundu S; Santra A; Dey B; Chakraborty M; Majumder PP
J Gastroenterol Hepatol; 2001 Sep; 16(9):1033-7. PubMed ID: 11595069
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetic association between
Khan S; Mandal RK; Elasbali AM; Dar SA; Jawed A; Wahid M; Mahto H; Lohani M; Mishra BN; Akhter N; Rabaan AA; Haque S
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509962
[TBL] [Abstract][Full Text] [Related]
35. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P
J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721
[TBL] [Abstract][Full Text] [Related]
36. Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies.
Wang FJ; Wang Y; Niu T; Lu WX; Sandford AJ; He JQ
J Clin Pharm Ther; 2016 Jun; 41(3):334-40. PubMed ID: 27062377
[TBL] [Abstract][Full Text] [Related]
37. NAT2 slow acetylator is associated with anti-tuberculosis drug-induced liver injury severity in indonesian population.
Yuliwulandari R; Prayuni K; Susilowati RW; M Sofro AS; Tokunaga K; Shin JG
Pharmacogenomics; 2019 Dec; 20(18):1303-1311. PubMed ID: 31699005
[No Abstract] [Full Text] [Related]
38. NAT2 Genotypes in Moroccan Patients with Hepatotoxicity Due to Antituberculosis Drugs.
Guaoua S; Ratbi I; El Bouazzi O; Hammi S; Tebaa A; Bourkadi JE; Bencheikh RS; Sefiani A
Genet Test Mol Biomarkers; 2016 Nov; 20(11):680-684. PubMed ID: 27541622
[TBL] [Abstract][Full Text] [Related]
39. Association of Cytochrome P450 2E1 and N-Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study.
Pourmohamadi N; Pour Abdollah Toutkaboni M; Hayati Roodbari N; Tabarsi P; Baniasadi S
Iran J Med Sci; 2023 Sep; 48(5):474-483. PubMed ID: 37786472
[TBL] [Abstract][Full Text] [Related]
40. Genomewide Association Study Confirming the Association of
Suvichapanich S; Wattanapokayakit S; Mushiroda T; Yanai H; Chuchottawon C; Kantima T; Nedsuwan S; Suwankesawong W; Sonsupap C; Pannarunothai R; Tumpattanakul S; Bamrungram W; Chaiwong A; Mahasirimongkol S; Mameechai S; Panthong W; Klungtes N; Munsoo A; Chauychana U; Maneerat M; Fukunaga K; Omae Y; Tokunaga K
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
